Training and workforce: an expert panel presents a new approach to epilepsy in the tropics by Scorza, Fulvio A. et al.
Training and workforce: an expert panel presents a
new approach to epilepsy in the tropics
Fulvio A. Scorza,I Elza M. Yacubian,II Lineu Calderazzo,I Carla A. Scorza,I Marly de Albuquerque,I Esper A.
CavalheiroI
IUniversidade Federal de Sa˜o Paulo/Escola Paulista de Medicina (UNIFESP/EPM), Disciplina de Neurologia Experimental, Sa˜o Paulo/SP, Brasil. IIUniversidade
Federal de Sa˜o Paulo/Escola Paulista de Medicina (UNIFESP/EPM). Departamento de Neurologia e Neurocirurgia, Unidade de Pesquisa e Tratamento das
Epilepsias, Sa˜o Paulo/SP, Brasil.
The development of new treatments and effective
strategies to prevent or reverse human diseases must be
the main goal of the health systems of a nation. This
objective is easily established when the system effectively
translates the results of biomedical research into clinical
practice and uses these results to make decisions regarding
health policies. Translational medicine is the basis of this
type of progress, constituting a continued process that
involves the direct application of discoveries made in
research laboratories to the development of studies in
human beings. In addition, translational medicine brings
together all the results from relevant studies and applies
them in clinical practice in an attempt to improve health
conditions and the quality of life of the population and
facilitate the adoption of the best medical practices by the
community. Thus, it has been recognized by the leading
scientific journals and the major funding agencies that
neuroscience is a biomedical field that is growing more
rapidly in the developing world than in developed world.
This observation is also valid for Latin American countries,
particularly Brazil. This fact can be clearly demonstrated by
the study performed by Nitrini in 2006, which evaluated 295
Brazilian clinical neuroscientists and their publications (1).
He showed that more than 40% of Brazilian papers were
published in Arquivos de Neuro-Psiquiatria, the official
journal of the Brazilian Academy of Neurology, and that
epilepsy is one of the sub-areas with the highest level of
scientific production (1). The focus of scientific research on
epilepsy is justified for several reasons.
According to the International League Against Epilepsy
(ILAE), epilepsy is defined as the transient occurrence of
signs and/or symptoms due to abnormal, excessive, or
synchronous neuronal activity in the brain (2). Epilepsy is a
neurological condition that knows no geographic, social, or
racial boundaries, occurring in men and women and affecting
people of all ages, although it more frequently affects young
people in the first two decades of life and people over the age
of 60 years (3,4). From an epidemiological point of view,
epilepsy is among the most common serious neurological
conditions, and it has a prevalence of approximately 1%
in developed countries (1,5). Annually, 24 per 100,000
persons suffer from epilepsy in Europe, and 53 per
100,000 are affected in North America (5-7). In developing
countries, the incidence is higher than that in industria-
lized countries, and up to 190 per 100,000 individuals
suffer from epilepsy (8,9).
Because epilepsy is a chronic disease, several factors have
a negative impact on the quality of life of patients with
epilepsy (3). There is a general consensus that stigma and
exclusion are common features of epilepsy in both devel-
oped and developing countries (3,10). Furthermore, epi-
lepsy often has profound physical, psychological, and social
consequences because seizures may cause misunderstand-
ing, fear, secrecy, stigmatization, and social isolation (3,10).
All facts reported above have been confirmed by the ILAE’s
reports, reinforcing the hypothesis that the psychosocial
effects experienced by persons with epilepsy are not always
a consequence of the course of the disease but often result
from discrimination and misconceptions about this condi-
tion (11).
From another perspective, we can ask the following
question: what are the main causes of epilepsy in the tropics
that result in these multifaceted problems? Certainly,
several factors may explain the high prevalence of epilepsy
in the tropics, such as a higher rate of exposure to prenatal
risk factors, a very high frequency of head injuries and the
presence of various parasitoses of the central nervous
system (CNS) (12-14). Among these causal factors, endemic
parasitic diseases are most likely the most common
preventable risk factors for epilepsy worldwide (12-14). In
the mid-1990s, the ILAE established a special Commission
on Tropical Diseases to comprehensively evaluate the
epidemiology, etiology, pathophysiology, immunologic
diagnosis, prognosis, treatment, and socioeconomic risk
factors to identify solutions to the problems faced by
patients with epilepsy in the tropics (15-17).
It has been demonstrated by several researchers that
various parasitic diseases are important causal factors of
epilepsy in individuals living in the tropics. These diseases
include neurocysticercosis, cerebral malaria, neurotoxoplas-
mosis, neuroschistosomiasis (bilharziasis), and cerebral
Chagas disease (American trypanosomiasis) (12,18).
According to the studies of Finester and Auer (18), because
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the outcome of cerebral parasitoses is dependent on early
and effective treatment, diagnostic procedures need to be
optimized and made available, particularly in endemic
areas (18). Furthermore, these researchers also believe that
parasitoses are still a worldwide health problem, the
solution for which requires the cooperative effort of global,
regional and local health authorities and also the education
of those at risk of becoming infected (18). Obviously, we are
in complete agreement with these suggestions and take the
opportunity to note that the global campaign evaluated in
1997 by the World Health Organization (WHO), the
International League Against Epilepsy (ILAE), and the
International Bureau for Epilepsy (IBE), called Global
Campaign against Epilepsy: Out of the Shadows, had as its
mission statement to improve the acceptability, treatment,
availability of services, and prevention of epilepsy worldwide
(19). To do so, several goals were carefully delineated to
increase public and professional awareness of epilepsy as a
universal, treatable brain disorder: to raise epilepsy to a new
plane of acceptability in the public domain; to identify the
needs of people with epilepsy on a national and regional basis;
to encourage governments and departments of health to
address the needs of people with epilepsy, including aware-
ness, education, diagnosis, treatment, care, services, and
prevention; and to promote public and professional education
about epilepsy (19). Regarding the educational efforts, Latin
American researchers have established plans and developed
highly specific actions with the aim of meeting these goals. The
Latin American Summer School on Epilepsy (LASSE), a
program run by the Educational Program of the ILAE with
the support of the Brazilian League of Epilepsy (BLE), has an
important role in meeting these goals.
In 2002, the summer schools on epilepsy became a new
didactic experience. These schools have been run by the
International School of Neurological Sciences, in Venice,
Italy, with the participation of researchers in basic and
clinical fields related to epilepsy. Because professors and
students are in contact for two consecutive weeks, this
specific school has facilitated the integration of these two
groups, allowing a better understanding of how new
discoveries benefit people with epilepsy. Based on this
successful experience and with the implementation of an
Educational Program for the ILAE in 2006, we are also
expanding this type of activity to the countries of Latin
America, with the objective of improving the knowledge of
the basic and clinical neuroscientists who are active in this
field. In brief, the aim of the LASSE is to teach attendees to
acquire basic knowledge about the pathophysiology of
epilepsy to promote the understanding of the clinical aspects
of epilepsies and to benefit from the mutual exchange of
information between basic scientists and clinicians.
Furthermore, it is important to note that the LASSE primarily
targets physicians currently in training or who have recently
specialized in neurology or other related fields and research
scientists from academia and the pharmaceutical industry
who have an active interest in epileptology.
Finally, we would like to note that we will continue to
offer such a summer course, and we have the great
satisfaction of announcing that, in 2013, the primary topic
of the VII LASSE will be Seizures and Epilepsy in the Tropics.
We are sure that this program will be highly successful,
with contributions from and participation by researchers
and students at all levels (undergraduate master’s and PhD)
in the field of neuroscience in Latin America.
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